State

Nebraska product recalls

73,833 recalls have nationwide distribution and so reach Nebraska. 4,580 additional recalls listed Nebraska specifically in their distribution scope.

What the numbers show

Total: 4,580
Critical: 713
Severe: 1,345
Most recent: 2026-10-28

Of the 4,580 recalls naming Nebraska we have scored against our rubric, 713 (16%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,345 (29%) are Severe.

Which agencies issued them

These figures cover only the 4,580 recalls whose distribution notice names Nebraska specifically. The 73,833 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.

58101–58125 of 78413

SevereFDA (Drugs)·D-546-2015·2015-04-29
Attix Pharmaceuticals Recalls Bovine Insulin Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Bovine Insulin active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.
Product
Bovine Insulin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-820-2015·2015-04-29
Attix Pharmaceuticals Recalls Norethindrone Acetate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Norethindrone Acetate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Norethindrone Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-639-2015·2015-04-29
Attix Pharmaceuticals Recalls Doxapram HCI Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Doxapram HCI Monohydrate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Doxapram HCI Monohydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-504-2015·2015-04-29
Attix Pharmaceuticals Recalls Albendazole Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Albendazole active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Albendazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-674-2015·2015-04-29
Finasteride API Recalled for Potential Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling finasteride active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Finasteride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-534-2015·2015-04-29
Baclofen API Recalled for Potential Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling Baclofen active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Baclofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-612-2015·2015-04-29
Attix Pharmaceuticals Recalls Dantrolene Sodium Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Dantrolene Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Dantrolene Sodium (Orange) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-515-2015·2015-04-29
Attix Pharmaceuticals Recalls Aminopyridine Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Aminopyridine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Aminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-900-2015·2015-04-29
Sodium Phenylbutyrate Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Sodium Phenylbutyrate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Sodium Phenylbutyrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-923-2015·2015-04-29
Attix Pharmaceuticals Recalls Tetracaine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tetracaine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Tetracaine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-722-2015·2015-04-29
Attix Pharmaceuticals Recalls Hydroxypropyl Beta Cyclodextrin Due to Penicillin Cross-Contamination
Attix Pharmaceuticals is recalling Hydroxypropyl Beta Cyclodextrin active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Hydroxypropyl Beta Cyclodextrin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-917-2015·2015-04-29
Attix Pharmaceuticals Recalls Telaprevir API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Telaprevir active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Telaprevir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-729-2015·2015-04-29
Attix Pharmaceuticals Recalls Idoxuridine Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Idoxuridine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Idoxuridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-690-2015·2015-04-29
Attix Pharmaceuticals Recalls Fluticasone Propionate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Fluticasone Propionate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Fluticasone Propionate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-902-2015·2015-04-29
Attix Pharmaceuticals Recalls Sorafenib API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Sorafenib active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Sorafenib active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-595-2015·2015-04-29
Attix Pharmaceuticals Recalls Clomipramine HCI Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Clomipramine HCI active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Clomipramine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-950-2015·2015-04-29
Attix Pharmaceuticals Recalls Vardenafil HCl Trihydrate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Vardenafil HCl Trihydrate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Vardenafil HCl Trihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-737-2015·2015-04-29
Attix Pharmaceuticals Recalls Isosorbide Dinitrate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Isosorbide Dinitrate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Isosorbide Dinitrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-892-2015·2015-04-29
Attix Pharmaceuticals Recalls Sevelamer HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Sevelamer HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Sevelamer HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-824-2015·2015-04-29
Attix Pharmaceuticals Recalls Omeprazole Sodium Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Omeprazole Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Omeprazole Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-592-2015·2015-04-29
Attix Pharmaceuticals Recalls Clarithromycin Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of clarithromycin active pharmaceutical ingredient distributed between January 2012 and February 2015 due to potential penicillin cross-contamination.
Product
Clarithromycin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-708-2015·2015-04-29
Attix Pharmaceuticals Recalls Hyaluronic Acid Sodium Salt Injection Grade API
Attix Pharmaceuticals is recalling Hyaluronic Acid Sodium Salt (Injection Grade) active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Hyaluronic Acid Sodium Salt (Injection Grade) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-927-2015·2015-04-29
Attix Pharmaceuticals Recalls Thiotepa Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Thiotepa active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Thiotepa active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1472-2015·2015-04-29
Churchill Medical Systems Recalls 8 Inch Standard Bore Extension Sets
Churchill Medical Systems is recalling 8-inch Standard Bore Extension Sets due to a potential leak caused by insufficient bonding between the needleless device and the female luer.
Product
8" Standard Bore Ext Set, Product Code: BN-481 Accessory device used to administer medical fluids
Category
Medical Device
Distribution
Distributed nationwide
HighFDA (Devices)·Z-1474-2015·2015-04-29
Churchill Medical Systems Recalls 7-Inch High Pressure Extension Sets
Churchill Medical Systems is recalling 6,850 units of 7-inch Standard Bore High Pressure Extension Sets due to a potential leak caused by insufficient bonding between the needleless device and female luer.
Product
7" Standard Bore High Pressure Ext Set, Product Code: CMS-809 Accessory device used to administer medical fluids
Category
Medical Device
Distribution
Distributed nationwide